Bank of America’s Metacrine, Inc. Common Stock MTCR Stock Holding History
Bought
Maintained
Sold
Other funds holding MTCR
BCM
JC
AG
WS
Bank of America's MTCR Position: Q1 2023 in Review
Bank of America sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 40 shares — an estimated $18 sold.
Bank of America first reported a position in MTCR in Q4 2020 and held it in 7 quarters. The position peaked at $244K in Q3 2021. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.
- Bank of America reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Bank of America sold 40 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $18.
- Bank of America first reported a position in Metacrine, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
- Bank of America's Metacrine, Inc. Common Stock position peaked at $244K in Q3 2021.
- 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.
Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.